Clostridium difficile in patients undergoing primary hip and knee replacement

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 7, 2010, Pages 994-998

  Jenkins, P J ^a   Teoh, K ^a   Simpson, P M ^a   Dave, J ^a   Simpson, A H W R ^a   Breusch, S ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR; TRIMETHOPRIM; VANCOMYCIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM CULTURE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; INCIDENCE; JOINT PROSTHESIS; KNEE ARTHROPLASTY; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPTICEMIA; STOMACH PROTECTION; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CEFUROXIME; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES;

EID: 77954269628     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B7.23412     Document Type: Article

References (25)

1. Kurd MF, Pulido L, Joshi A, Purtill JJ, Parvizi J. Clostridium difficile infection after total joint arthroplasty: who is at risk? J Arthroplasty 2008;23:839-42.
2. Jumaa P, Wren B, Tabaqchali S. Epidemiology and typing of Clostridium difficile. Eur J Gastroenterol Hepatol 1996;8:1035-40.
3. Settle CD. Clostridium difficile. Br J Hosp Med 1996;56:398-400.
4. Job ML, Jacobs NF Jr. Drug-induced Clostridium difficile-associated disease. Drug Saf 1997;17:37-46.
5. Farrell RJ, LaMont JT. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol 2000;250:109-25.
6. Harbarth S, Samore MH, Carmeli Y. Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J Hosp Infect 2001;48:93-7.
7. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405-10.
8. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-44. (Pubitemid 34568654)
9. Dancer SJ. The problem with cephalosporins. J Antimicrob Chemother 2001;48:463-78.
10. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008;16:283-93.
11. Fletcher N, Sofianos D, Berkes MB, Obremsky WT. Prevention of perioperative infection. J Bone Joint Surg [Am] 2007;89-A:1605-18.
12. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006;66:1089-105.
13. Marculescu CE, Osmon DR. Antibiotic prophylaxis in orthopaedic prosthetic surgery. Infect Dis Clin North Am 2005;19:931-46.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
15. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg [Br] 2008;90-B:915-19.
16. Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systematically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74:644-51.
17. No authors listed. Scottish Intercollegiate Guideline Network (SIGN). Antibiotic Prophylaxis in Surgery. No 104, July 2008. http://www.sign.ac.uk/pdf/ sign104/pdf (date last accessed 15 March 2010).
18. Slobogean GP, Kennedy SA, Davidson D, O'Brien PJ. Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a metaanalysis. J Orthop Trauma 2008;22:264-9.
19. Starks I, Ayub G, Walley G, et al. Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 2008;70:21-6.
20. Privitera G, Scarpellini P, Ortisi G, et al. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother 1991;35:208-10.
21. Ambrose NS, Johnson M, Burdon DW, Keighley MR. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. J Antimicrob Chemother 1985;15:319-26. (Pubitemid 15112917)
22. Dellamonica P, Bernard E. Fluouroquinolones and surgical prophylaxis. Drugs 1993;45 (Suppl 3):102-13.
23. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243-5.
24. Jayatilaka S, Shakov R, Eddi R, et al. Clostridium difficile infection in an urban medical centre: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Ann Clin Lab Sci 2007;37:241-7. (Pubitemid 47311340)
25. Kaur S, Vaishnavi C, Prasad KK, Ray P, Kochhar R. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice. Microbiol Immunol 2007;51:1209-14.